Annals of Oncology

Editorials:

J. O. Armitage, J. M. Vose, and D. D. Weisenburger

Towards understanding the peripheral T-cell lymphomas
Ann Oncol 15: 1447-1449; doi:10.1093/annonc/mdh409
[Extract] [FREE Full Text] [PDF] [Request Permissions]

E. Montserrat

Assessing prognosis in patients with chronic lymphocytic leukemia a quarter of a century after Rai and Binet staging systems
Ann Oncol 15: 1450-1451; doi:10.1093/annonc/mdh408
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

C. J. A. Punt

New options and old dilemmas in the treatment of patients with advanced colorectal cancer
Ann Oncol 15: 1453-1459; doi:10.1093/annonc/mdh383
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. R. Weihrauch and V. Diehl

Artificial sweeteners—do they bear a carcinogenic risk?
Ann Oncol 15: 1460-1465; doi:10.1093/annonc/mdh256
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Hematologic malignancies:

K. J. Savage, M. Chhanabhai, R. D. Gascoyne, and J. M. Connors

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification
Ann Oncol 15: 1467-1475; doi:10.1093/annonc/mdh392
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Tchirkov, C. Chaleteix, C. Magnac, Y. Vasconcelos, F. Davi, A. Michel, F. Kwiatkowski, O. Tournilhac, G. Dighiero, and P. Travade

hTERT expression and prognosis in B-chronic lymphocytic leukemia
Ann Oncol 15: 1476-1480; doi:10.1093/annonc/mdh389
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. P. Treon, A. R. Branagan, Z. Hunter, D. Santos, O. Tournhilac, and K. C. Anderson

Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia
Ann Oncol 15: 1481-1483; doi:10.1093/annonc/mdh403
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. Montoto, A. López-Guillermo, A. Altés, G. Perea, A. Ferrer, M. Camós, L. Villela, F. Bosch, J. Esteve, F. Cervantes, J. Bladé, B. Nomdedeu, E. Campo, J. Sierra, and E. Montserrat

Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression
Ann Oncol 15: 1484-1489; doi:10.1093/annonc/mdh406
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. Sallah, A. Husain, J. Wan, P. Vos, and N. P. Nguyen

The risk of venous thromboembolic disease in patients with monoclonal gammopathy of undetermined significance
Ann Oncol 15: 1490-1494; doi:10.1093/annonc/mdh385
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. S. Portlock, J. Qin, P. Schaindlin, N. Roistacher, J. Myers, D. Filippa, D. Louie, A. D. Zelenetz, J. P. O'Brien, C. Moskowitz, L. Norton, J. Yahalom, D. J. Straus, and J. R. Bertino

The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide
Ann Oncol 15: 1495-1503; doi:10.1093/annonc/mdh390
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Rodriguez, M. D. Caballero, A. Gutierrez, C. Solano, R. Arranz, J. J. Lahuerta, J. Sierra, M. Gandarillas, J. A. Perez-Simon, J. Zuazu, A. Lopez-Guillermo, A. Sureda, E. Carreras, J. Garcia-Laraña, J. Marin, J. C. Garcia, A. Fernandez de Sevilla, J. Rifon, R. Varela, I. Jarque, C. Albo, A. Leon, J. SanMiguel, and E. Conde

Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience
Ann Oncol 15: 1504-1509; doi:10.1093/annonc/mdh391
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Breast cancer:

L. A. deGraffenried, L. Fulcher, W. E. Friedrichs, V. Grünwald, R. B. Ray, and M. Hidalgo

Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway
Ann Oncol 15: 1510-1516; doi:10.1093/annonc/mdh388
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Fountzilas, H. P. Kalofonos, U. Dafni, C. Papadimitriou, D. Bafaloukos, P. Papakostas, A. Kalogera-Fountzila, H. Gogas, G. Aravantinos, L. A. Moulopoulos, T. Economopoulos, D. Pectasides, N. Maniadakis, V. Siafaka, E. Briasoulis, C. Christodoulou, D. Tsavdaridis, P. Makrantonakis, E. Razis, P. Kosmidis, D. Skarlos, and M. A. Dimopoulos

Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group
Ann Oncol 15: 1517-1526; doi:10.1093/annonc/mdh395
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. Chan, N. Davidson, E. Juozaityte, F. Erdkamp, A. Pluzanska, N. Azarnia, and L. W. Lee

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer
Ann Oncol 15: 1527-1534; doi:10.1093/annonc/mdh393
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gynecologic tumors:

C. Faleiro-Rodrigues, I. Macedo-Pinto, D. Pereira, and C. S. Lopes

Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas
Ann Oncol 15: 1535-1542; doi:10.1093/annonc/mdh387
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Miscellaneous tumors:

V. R. Rozados, A. M. Sánchez, S. I. Gervasoni, H. H. Berra, P. Matar, and O. Graciela Scharovsky

Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity
Ann Oncol 15: 1543-1550; doi:10.1093/annonc/mdh384
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Oncology practice:

T. Morita, T. Akechi, M. Ikenaga, Y. Kizawa, H. Kohara, T. Mukaiyama, T. Nakaho, N. Nakashima, Y. Shima, T. Matsubara, M. Fujimori, and Y. Uchitomi

Communication about the ending of anticancer treatment and transition to palliative care
Ann Oncol 15: 1551-1557; doi:10.1093/annonc/mdh386
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

D. Elias, T. Matsuhisa, L. Sideris, G. Liberale, L. Drouard-Troalen, B. Raynard, M. Pocard, J. M. Puizillou, V. Billard, P. Bourget, and M. Ducreux

Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance
Ann Oncol 15: 1558-1565; doi:10.1093/annonc/mdh398
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

E. Briasoulis, G. Pentheroudakis, V. Karavasilis, E. Tzamakou, D. Rammou, and N. Pavlidis

Weekly paclitaxel combined with pegylated liposomal doxorubicin (Caelyx^TM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors
Ann Oncol 15: 1566-1573; doi:10.1093/annonc/mdh404
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

G. Utkan, A. Büyükçelik, and B. Yalçyn

The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer
Ann Oncol 15: 1574; doi:10.1093/annonc/mdh396
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. Tripathy

Reply to Letter to the Editor on "The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer", by G. Utkan, A. Büyükçelik, B. Yalçn (Ann Oncol 2004; 15: 1574)
Ann Oncol 15: 1574-1575; doi:10.1093/annonc/mdh394
[Extract] [FREE Full Text] [PDF] [Request Permissions]

I. Ruiz, J. Del Valle, and A. Gómez

Gemcitabine and haemolytic-uraemic syndrome
Ann Oncol 15: 1575-1576; doi:10.1093/annonc/mdh397
[Extract] [FREE Full Text] [PDF] [Request Permissions]

S. Spazzapan, A. Bearz, and U. Tirelli

Fatigue in cancer patients receiving chemotherapy: an analysis of published studies
Ann Oncol 15: 1576; doi:10.1093/annonc/mdh400
[Extract] [FREE Full Text] [PDF] [Request Permissions]

C. Alliot

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-fluorouracil and infusional 5-fluorouracil alone in advanced pancreatic carcinoma patients
Ann Oncol 15: 1576-1577; doi:10.1093/annonc/mdh401
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. Ducreux, E. Mitry, M. Ould-Kaci, V. Boige, J. F. Seitz, R. Bugat, J. L. Breau, O. Bouché, P. L. Etienne, J. M. Tigaud, F. Morvan, E. Cvitkovic, and P. Rougier

Response to the letter "Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU and infusional 5-FU alone in advanced pancreatic carcinoma patients", by C. Allior (Ann. Oncol 2004; 15: 1576–1577)
Ann Oncol 15: 1577-1578; doi:10.1093/annonc/mdh402
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

A.-S. Michallet

Clinical Bone Marrow and Blood Stem Cell Transplantation, 3rd edition
Ann Oncol 15: 1579; doi:10.1093/annonc/mdh405
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.